Suchergebnisse - "Clavio, Marino"

PubPharm (98)

1

Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation

enthalten in: European journal of haematology | 2021

von Guolo, F. | Di Grazia, C. | Minetto, P. | +22

2

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice

enthalten in: Cancer | 2021

von Clavio, M. | Crisà, E. | Miglino, M. | +28

3

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma : A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells

enthalten in: Frontiers in immunology | 2021

von Guolo, F. | Minetto, P. | Pesce, S. | +26

4

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice

enthalten in: Cancer | 2021

von Clavio, M. | Crisà, E. | Miglino, M. | +28

5

Pre‐transplant minimal residual disease assessment and transplant‐related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation

enthalten in: European Journal of Haematology | 2021

von Guolo, F. | Di Grazia, C. | Minetto, P. | +22

6

Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden

enthalten in: Cancers | 2020

von Minetto, P. | Candoni, A. | Guolo, F. | +18

7

Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML

enthalten in: Blood advances | 2020

von Visani, G. | Loscocco, F. | Dennis, M. | +13

8

SARS-CoV-2 in Myelodysplastic Syndromes : A Snapshot From Early Italian Experience

enthalten in: HemaSphere | 2020

von Mossuto, S. | Attardi, E. | Alesiani, F. | +50

9

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation : results of the Italian compassionate use program

enthalten in: Blood cancer journal | 2020

von Guolo, F. | Fianchi, L. | Minetto, P. | +33

10

The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs

enthalten in: Haematologica | 2020

von Soncini, D. | Orecchioni, S. | Ruberti, S. | +22

CommentIn: Haematologica. 2020 Jun 05;105(10):2350-2352. - PMID 33054073

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]